Option Care Health Revenue Up, Net Income Dips Amid Acquisition Costs

Ticker: OPCH · Form: 10-Q · Filed: Oct 30, 2025 · CIK: 1014739

Sentiment: mixed

Topics: Healthcare Services, Infusion Therapy, Acquisition, Stock Repurchase, Revenue Growth, Net Income Decline, Debt Increase

TL;DR

**OPCH's revenue growth is solid, but the cash burn on buybacks and acquisitions, coupled with a net income dip, makes me cautious; watch for integration success.**

AI Summary

Option Care Health, Inc. (OPCH) reported a mixed financial performance for the nine months ended September 30, 2025. Net revenue increased by 14.57% to $4.184 billion from $3.652 billion in the prior year period. However, net income slightly decreased by 1.72% to $149.081 million from $151.690 million, primarily due to higher operating costs and increased interest expense. Operating income grew by 4.94% to $246.405 million. The company completed the acquisition of Intramed Plus, Inc. on January 24, 2025, for $117.2 million, which contributed to an increase in goodwill by $66.4 million to $1.607 billion. Cash and cash equivalents decreased significantly by 25.09% to $309.822 million from $412.565 million at December 31, 2024, largely due to $214.887 million spent on company stock purchases and $117.247 million on business acquisitions. Long-term debt, net, increased by $50.415 million to $1.155 billion. The company continues to face concentration risk with its largest payer accounting for 14% of revenue and four vendors supplying 67% of pharmaceutical purchases.

Why It Matters

For investors, the revenue growth of 14.57% is positive, but the slight dip in net income and significant cash outflow for stock repurchases and acquisitions warrant closer scrutiny. The Intramed Plus acquisition, valued at $117.2 million, indicates strategic expansion, but its integration and profitability will be key. Employees and customers might see expanded service offerings and geographic reach due to the acquisition. The broader market for infusion services remains competitive, and OPCH's ability to manage rising operating costs and maintain payer relationships will be crucial for sustained growth and market share against rivals.

Risk Assessment

Risk Level: medium — The company faces a medium risk level due to significant cash outflows for stock repurchases ($214.887 million) and business acquisitions ($117.247 million), leading to a 25.09% decrease in cash and cash equivalents. Additionally, there's a concentration risk with the largest payer representing 14% of revenue and four vendors supplying 67% of pharmaceutical purchases, as stated in Note 2.

Analyst Insight

Investors should monitor the integration of Intramed Plus and its contribution to future profitability. Evaluate the effectiveness of the $214.887 million in stock repurchases in boosting shareholder value, especially given the decrease in net income. Keep an eye on the company's ability to diversify its payer base and supplier relationships to mitigate concentration risks.

Financial Highlights

debt To Equity
1.56
revenue
$4.184B
operating Margin
5.90%
total Assets
$3.480B
total Debt
$1.162B
net Income
$149.081M
eps
$0.91
gross Margin
19.24%
cash Position
$309.822M
revenue Growth
+14.57%

Key Numbers

Key Players & Entities

FAQ

What were Option Care Health's net revenues for the nine months ended September 30, 2025?

Option Care Health's net revenues for the nine months ended September 30, 2025, were $4,184,073 thousand, an increase from $3,651,784 thousand for the same period in 2024.

How did Option Care Health's net income change for the nine months ended September 30, 2025?

Net income for Option Care Health decreased slightly to $149,081 thousand for the nine months ended September 30, 2025, compared to $151,690 thousand for the same period in 2024.

What was the impact of the Intramed Plus acquisition on Option Care Health?

Option Care Health acquired Intramed Plus, Inc. on January 24, 2025, for a purchase price of $117.2 million, net of cash acquired. This acquisition contributed to an increase in goodwill by $66.4 million.

What is Option Care Health's cash and cash equivalents position as of September 30, 2025?

As of September 30, 2025, Option Care Health's cash and cash equivalents stood at $309,822 thousand, a decrease from $412,565 thousand at December 31, 2024.

What are the key risks related to Option Care Health's revenue concentration?

Option Care Health faces a concentration risk as its largest payer accounted for approximately 14% of revenue for the three and nine months ended September 30, 2025. This reliance on a single payer could impact financial stability if the relationship changes.

How much did Option Care Health spend on purchasing its own stock?

For the nine months ended September 30, 2025, Option Care Health spent $214,887 thousand on the purchase of company stock and related excise taxes.

What is Option Care Health's long-term debt position?

Option Care Health's long-term debt, net of discount, deferred financing costs, and current portion, was $1,155,056 thousand as of September 30, 2025, an increase from $1,104,641 thousand at December 31, 2024.

What percentage of Option Care Health's revenue comes from government healthcare programs?

For the three and nine months ended September 30, 2025, approximately 12% of Option Care Health's revenue was reimbursable through direct government healthcare programs, such as Medicare and Medicaid.

What is the concentration risk regarding Option Care Health's pharmaceutical suppliers?

Approximately 67% of Option Care Health's pharmaceutical and medical supply purchases for the nine months ended September 30, 2025, were from four vendors, indicating a concentration risk in its supply chain.

What were the basic and diluted earnings per share for Option Care Health for the nine months ended September 30, 2025?

For the nine months ended September 30, 2025, Option Care Health reported basic earnings per share of $0.91 and diluted earnings per share of $0.91.

Risk Factors

Industry Context

Option Care Health operates in the home healthcare and infusion services sector, a market characterized by increasing demand for post-acute care and specialized therapies delivered in patient homes. The industry faces evolving reimbursement models, regulatory scrutiny, and consolidation pressures. Key trends include the shift towards value-based care, technological advancements in remote patient monitoring, and the growing need for services catering to chronic and complex conditions.

Regulatory Implications

The healthcare industry is subject to extensive regulation, including compliance with Medicare and Medicaid rules, HIPAA privacy standards, and state licensing requirements. Changes in healthcare policy, such as reimbursement rate adjustments or new compliance mandates, can significantly impact profitability and operational strategies. Option Care Health must maintain robust compliance programs to mitigate risks associated with these regulations.

What Investors Should Do

  1. Monitor Payer and Vendor Concentration
  2. Analyze Cash Flow and Debt Management
  3. Evaluate Acquisition Integration Success
  4. Assess Operating Margin Trends

Key Dates

Glossary

Goodwill
An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. It represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. (The increase in goodwill by $66.4 million to $1.607 billion reflects the acquisition of Intramed Plus, Inc., indicating the premium paid over the fair value of acquired net assets.)
Treasury Stock
Stock that a company has repurchased from the open market. It is recorded at cost and appears as a contra-equity account, reducing total stockholders' equity. (The significant increase in treasury stock (from $507.6 million to $722.2 million) indicates substantial share repurchases, which reduced the number of outstanding shares and contributed to the increase in EPS.)
Diluted EPS
Earnings per share calculated using the weighted average number of outstanding common shares plus all dilutive potential common shares (such as stock options and convertible securities). (Diluted EPS increased to $0.91 from $0.87, despite lower net income, due to a reduction in the number of outstanding shares resulting from stock repurchases.)
Operating Lease Right-of-Use Asset
An asset recognized under accounting standards for leases, representing the lessee's right to use an underlying asset for the lease term. (This asset, along with its corresponding liability, reflects the company's long-term rental commitments for facilities and equipment.)

Year-Over-Year Comparison

Compared to the prior year period, Option Care Health reported a solid 14.57% increase in net revenue to $4.184 billion for the nine months ended September 30, 2025. However, net income saw a slight decrease of 1.72% to $149.081 million, primarily due to higher operating costs and increased interest expenses. The company's cash position has weakened significantly, with cash and cash equivalents down 25.09%, driven by substantial stock repurchases and acquisitions. Long-term debt has also increased, raising leverage concerns. New risks related to vendor concentration and the integration of recent acquisitions are also noteworthy.

Filing Stats: 4,661 words · 19 min read · ~16 pages · Grade level 14.8 · Accepted 2025-10-30 16:02:19

Key Financial Figures

Filing Documents

Financial Statements

Financial Statements 4 Condensed Consolidated Balance Sheets 5 Unaudited Condensed Consolidated Statements of Comprehensive Income 6 Unaudited Condensed Consolidated Statements of Cash Flows 7 Unaudited Condensed Consolidated Statements of Stockholders' Equity 8 Notes to Unaudited Condensed Consolidated Financial Statements 9 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 22 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 34 Item 4.

Controls and Procedures

Controls and Procedures 34 PART II Item 1.

Legal Proceedings

Legal Proceedings 35 Item 1A.

Risk Factors

Risk Factors 35 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 35 Item 5. Other Information 35 Item 6. Exhibits 36

SIGNATURES

SIGNATURES 37 2 Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q (this "Form 10-Q") to "Option Care Health," the "Company," "we," "us" and "our" refer to Option Care Health, Inc. and its consolidated subsidiaries.

Forward-Looking Statements

Forward-Looking Statements This Form 10-Q includes forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, without limitation, statements concerning our expectations regarding industry and macroeconomic trends and our operating performance. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "believe," "project," "estimate," "expect," "may," "should," "will" and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. If any of these risks materialize, or if any of our assumptions underlying forward-looking statements prove incorrect, actual results and developments may differ materially from those made in or suggested by the forward-looking statements contained in this Form 10-Q. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, those set forth in Item 1A, "Risk Factors," of Part I of our Annual Report on Form 10-K for the year ended December 31, 2024 (our "Form 10-K") filed with the U.S. Securities and Exchange Commission (the "SEC"). Although we have attempted to identify important risk factors, there may be other risk factors not presently known to us or that we presently believe are not material that could cause actual results and developments to differ materially from those made in or sugg

Financial Statements

Item 1. Financial Statements 4 Table of Contents OPTION CARE HEALTH, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (IN THOUSANDS, EXCEPT SHARES AND PER SHARE AMOUNTS) September 30, 2025 December 31, 2024 (unaudited) ASSETS CURRENT ASSETS: Cash and cash equivalents $ 309,822 $ 412,565 Accounts receivable, net 474,500 409,733 Inventories 415,723 388,131 Prepaid expenses and other current assets 82,721 112,198 Total current assets 1,282,766 1,322,627 NONCURRENT ASSETS: Property and equipment, net 134,298 127,367 Operating lease right-of-use asset 92,439 86,528 Intangible assets, net 22,732 16,993 Referral sources, net 295,716 284,017 Goodwill 1,606,646 1,540,246 Other noncurrent assets 45,248 43,965 Total noncurrent assets 2,197,079 2,099,116 TOTAL ASSETS $ 3,479,845 $ 3,421,743 LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES: Accounts payable $ 627,867 $ 610,779 Accrued compensation and employee benefits 72,460 63,028 Accrued expenses and other current liabilities 93,324 77,783 Current portion of operating lease liability 23,475 22,044 Current portion of long-term debt 6,780 6,512 Total current liabilities 823,906 780,146 NONCURRENT LIABILITIES: Long-term debt, net of discount, deferred financing costs and current portion 1,155,056 1,104,641 Operating lease liability, net of current portion 90,894 84,776 Deferred income taxes 50,019 47,576 Other noncurrent liabilities 1,311 366 Total noncurrent liabilities 1,297,280 1,237,359 Total liabilities 2,121,186 2,017,505 STOCKHOLDERS' EQUITY: Preferred stock; $ 0.0001 par value; 12,500,000 shares authorized, no shares outstanding as of September 30, 2025 and December 31, 2024 — — Common stock; $ 0.0001 par value: 250,000,000 shares authorized, 184,498,929 shares issued and 160,107,695 shares outstanding as of September 30, 2025; 183,846,725 shares issued and 166,261,112 shares outstanding as of December 31, 2024 18 18 Treasury stock; 24,391,234 and 17,585,613 shares out

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing